<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">J Clin Oncol</journal-id>
        <journal-id journal-id-type="iso-abbrev">J. Clin. Oncol</journal-id>
        <journal-id journal-id-type="pmc-domain-id">660</journal-id>
        <journal-id journal-id-type="pmc-domain">jco</journal-id>
        <journal-id journal-id-type="publisher-id">JCO</journal-id>
        <journal-title-group>
          <journal-title>Journal of Clinical Oncology</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0732-183X</issn>
        <issn pub-type="epub">1527-7755</issn>
        <publisher>
          <publisher-name>American Society of Clinical Oncology</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC6075848</article-id>
        <article-id pub-id-type="pmcid-ver">PMC6075848.1</article-id>
        <article-id pub-id-type="pmcaid">6075848</article-id>
        <article-id pub-id-type="pmcaiid">6075848</article-id>
        <article-id pub-id-type="pmid">29337640</article-id>
        <article-id pub-id-type="doi">10.1200/JCO.2017.75.3384</article-id>
        <article-id pub-id-type="publisher-id">753384</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="subjects">
            <compound-subject>
              <compound-subject-part content-type="code">THOR12</compound-subject-part>
              <compound-subject-part content-type="label">Translational Oncology</compound-subject-part>
            </compound-subject>
            <compound-subject>
              <compound-subject-part content-type="code">TO2</compound-subject-part>
              <compound-subject-part content-type="label">Cancer Biomarkers</compound-subject-part>
            </compound-subject>
            <compound-subject>
              <compound-subject-part content-type="code">TO6</compound-subject-part>
              <compound-subject-part content-type="label">Immunology/Immunobiology</compound-subject-part>
            </compound-subject>
          </subj-group>
          <subj-group subj-group-type="heading">
            <subject>ORIGINAL REPORTS</subject>
            <subj-group>
              <subject>Thoracic Oncology</subject>
            </subj-group>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing</article-title>
          <alt-title alt-title-type="short">Predictors of Immunotherapy Response Derived From Targeted NGS</alt-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rizvi</surname>
              <given-names initials="H">Hira</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sanchez-Vega</surname>
              <given-names initials="F">Francisco</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>La</surname>
              <given-names initials="K">Konnor</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chatila</surname>
              <given-names initials="W">Walid</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Jonsson</surname>
              <given-names initials="P">Philip</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Halpenny</surname>
              <given-names initials="D">Darragh</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Plodkowski</surname>
              <given-names initials="A">Andrew</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Long</surname>
              <given-names initials="N">Niamh</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sauter</surname>
              <given-names initials="JL">Jennifer L.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rekhtman</surname>
              <given-names initials="N">Natasha</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hollmann</surname>
              <given-names initials="T">Travis</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schalper</surname>
              <given-names initials="KA">Kurt A.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gainor</surname>
              <given-names initials="JF">Justin F.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shen</surname>
              <given-names initials="R">Ronglai</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ni</surname>
              <given-names initials="A">Ai</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Arbour</surname>
              <given-names initials="KC">Kathryn C.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Merghoub</surname>
              <given-names initials="T">Taha</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wolchok</surname>
              <given-names initials="J">Jedd</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Snyder</surname>
              <given-names initials="A">Alexandra</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chaft</surname>
              <given-names initials="JE">Jamie E.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kris</surname>
              <given-names initials="MG">Mark G.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rudin</surname>
              <given-names initials="CM">Charles M.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Socci</surname>
              <given-names initials="ND">Nicholas D.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names initials="BS">Barry S.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zehir</surname>
              <given-names initials="A">Ahmet</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Solit</surname>
              <given-names initials="DB">David B.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Arcila</surname>
              <given-names initials="ME">Maria E.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ladanyi</surname>
              <given-names initials="M">Marc</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Riely</surname>
              <given-names initials="GJ">Gregory J.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schultz</surname>
              <given-names initials="N">Nikolaus</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hellmann</surname>
              <given-names initials="MD">Matthew D.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
            <xref ref-type="corresp" rid="cor1"/>
          </contrib>
          <aff id="aff1">Hira Rizvi, Francisco Sanchez-Vega, Konnor La, Walid Chatila, Philip Jonsson, Darragh Halpenny, Andrew Plodkowski, Niamh Long, Jennifer L. Sauter, Natasha Rekhtman, Travis Hollmann, Ronglai Shen, Ai Ni, Kathryn C. Arbour, Taha Merghoub, Jedd Wolchok, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Nicholas D. Socci, Michael F. Berger, Barry S. Taylor, Ahmet Zehir, David B. Solit, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Nikolaus Schultz, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Taha Merghoub, Jedd Wolchok, Alexandra Snyder, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Gregory J. Riely, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Kurt A. Schalper, Yale School of Medicine, New Haven, CT; Justin F. Gainor, Massachusetts General Hospital, Boston, MA; and Alexandra Snyder, Adaptive Biotechnologies, Seattle, WA.</aff>
        </contrib-group>
        <author-notes>
          <fn id="afn1" fn-type="equal">
            <p>H.R. and F.S.-V. contributed equally to this work.</p>
          </fn>
          <corresp id="cor1">Corresponding author: Matthew D. Hellmann, MD, Memorial Sloan Kettering Cancer Center, 885 2nd Ave, New York, NY 10017; e-mail: <email>hellmanm@mskcc.org</email>.</corresp>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>1</day>
          <month>3</month>
          <year>2018</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>16</day>
          <month>1</month>
          <year>2018</year>
        </pub-date>
        <volume>36</volume>
        <issue>7</issue>
        <issue-id pub-id-type="pmc-issue-id">312621</issue-id>
        <fpage>633</fpage>
        <lpage>641</lpage>
        <pub-history>
          <event event-type="pmc-release">
            <date>
              <day>01</day>
              <month>08</month>
              <year>2018</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>07</day>
              <month>08</month>
              <year>2018</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-02-15 00:25:12.480">
              <day>15</day>
              <month>02</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement>© 2018 by American Society of Clinical Oncology</copyright-statement>
          <copyright-year>2018</copyright-year>
          <copyright-holder>American Society of Clinical Oncology</copyright-holder>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JCO.2017.75.3384.pdf"/>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:title="pdf" xlink:href="JCO.2017.75.3384.pdf"/>
        <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" xlink:title="editorial" journal-id="Transl Lung Cancer Res" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC6987355">
          <article-title>Targeted next-generation sequencing to assess tumor mutation burden: ready for prime-time in non-small cell lung cancer?</article-title>
          <volume>8</volume>
          <issue>Suppl 4</issue>
          <date>
            <month>12</month>
            <year>2019</year>
          </date>
          <fpage>S323</fpage>
          <lpage>S326</lpage>
          <source>Translational Lung Cancer Research</source>
          <pub-id pub-id-type="pmcid">PMC6987355</pub-id>
          <pub-id pub-id-type="pmid">32038906</pub-id>
        </related-article>
        <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="correction-forward" xml:lang="en" xlink:title="correction" journal-id="J Clin Oncol" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC6161944">
          <article-title>Erratum</article-title>
          <volume>36</volume>
          <issue>16</issue>
          <date>
            <day>1</day>
            <month>6</month>
            <year>2018</year>
          </date>
          <fpage>1645</fpage>
          <lpage>1645</lpage>
          <source>Journal of Clinical Oncology</source>
          <pub-id pub-id-type="pmcid">PMC6161944</pub-id>
          <pub-id pub-id-type="pmid">31329702</pub-id>
        </related-article>
        <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="companion" xml:lang="en" journal-id="J Clin Oncol" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="29337637">
          <article-title>Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine?</article-title>
          <date>
            <day>16</day>
            <month>1</month>
            <year>2018</year>
          </date>
          <fpage>JCO2017768770</fpage>
          <lpage>JCO2017768770</lpage>
          <source>J Clin Oncol</source>
          <pub-id pub-id-type="doi">10.1200/JCO.2017.76.8770</pub-id>
          <pub-id pub-id-type="pmid">29337637</pub-id>
        </related-article>
        <abstract>
          <sec>
            <title>Purpose</title>
            <p>Treatment of advanced non–small-cell lung cancer with immune checkpoint inhibitors (ICIs) is characterized by durable responses and improved survival in a subset of patients. Clinically available tools to optimize use of ICIs and understand the molecular determinants of response are needed. Targeted next-generation sequencing (NGS) is increasingly routine, but its role in identifying predictors of response to ICIs is not known.</p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>Detailed clinical annotation and response data were collected for patients with advanced non–small-cell lung cancer treated with anti–programmed death-1 or anti–programmed death-ligand 1 [anti-programmed cell death (PD)-1] therapy and profiled by targeted NGS (MSK-IMPACT; n = 240). Efficacy was assessed by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, and durable clinical benefit (DCB) was defined as partial response/stable disease that lasted &gt; 6 months. Tumor mutation burden (TMB), fraction of copy number–altered genome, and gene alterations were compared among patients with DCB and no durable benefit (NDB). Whole-exome sequencing (WES) was performed for 49 patients to compare quantification of TMB by targeted NGS versus WES.</p>
          </sec>
          <sec>
            <title>Results</title>
            <p>Estimates of TMB by targeted NGS correlated well with WES (ρ = 0.86; <italic toggle="yes">P</italic> &lt; .001). TMB was greater in patients with DCB than with NDB (<italic toggle="yes">P</italic> = .006). DCB was more common, and progression-free survival was longer in patients at increasing thresholds above versus below the 50th percentile of TMB (38.6% <italic toggle="yes">v</italic> 25.1%; <italic toggle="yes">P</italic> &lt; .001; hazard ratio, 1.38; <italic toggle="yes">P</italic> = .024). The fraction of copy number–altered genome was highest in those with NDB. Variants in <italic toggle="yes">EGFR</italic> and <italic toggle="yes">STK11</italic> associated with a lack of benefit. TMB and PD-L1 expression were independent variables, and a composite of TMB plus PD-L1 further enriched for benefit to ICIs.</p>
          </sec>
          <sec>
            <title>Conclusion</title>
            <p>Targeted NGS accurately estimates TMB and elevated TMB further improved likelihood of benefit to ICIs. TMB did not correlate with PD-L1 expression; both variables had similar predictive capacity. The incorporation of both TMB and PD-L1 expression into multivariable predictive models should result in greater predictive power.</p>
          </sec>
        </abstract>
        <counts>
          <fig-count count="17"/>
          <table-count count="5"/>
          <equation-count count="0"/>
          <ref-count count="38"/>
          <page-count count="35"/>
        </counts>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name> SJS Export </meta-name>
            <meta-value>v1</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
